[Vinblastine + procarbazine + cyclophosphamide association in the treatment of Hodgkin's disease (author's transl)].
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy* / Q000532:radiotherapy; D006801:Humans; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage / Q000627:therapeutic use*; D008875:Middle Aged; D011344:Procarbazine / Q000008:administration & dosage / Q000627:therapeutic use*; D012075:Remission, Spontaneous; D014747:Vinblastine / Q000008:administration & dosage / Q000627:therapeutic use*
D011344:Procarbazine; D014747:Vinblastine; D003520:Cyclophosphamide; D008775:Methylprednisolone
Chimiothérapie de la maladie de Hodgkin associant procarbazine, vinblastine, cyclophosphamide et méthyl-prednisolone.